Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk
- 1 November 2006
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (16) , 2833-2837
- https://doi.org/10.1016/j.ejca.2006.06.030
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer riskCarcinogenesis: Integrative Cancer Research, 2002
- The CAG trinucleotide repeat length in the androgen receptor does not predict the early onset of prostate cancerBJU International, 2002
- The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European populationJournal of Human Genetics, 2002
- Androgen receptor CAG polymorphism and prostate cancer riskHuman Genetics, 2002
- Significance of Vitamin D Receptor Gene Polymorphism for Risk and Disease Severity of Prostate Cancer and Benign Prostatic Hyperplasia in JapaneseUrologia Internationalis, 2002
- (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French–German populationEuropean Journal of Human Genetics, 1999
- Association of Prostate Cancer Risk With Genetic Polymorphisms in Vitamin D Receptor and Androgen ReceptorJNCI Journal of the National Cancer Institute, 1997
- Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onsetJournal of Clinical Endocrinology & Metabolism, 1996
- Prediction of bone density from vitamin D receptor allelesNature, 1994
- The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation functionNucleic Acids Research, 1994